🔴 This is an archived resource.
This resource has not been reviewed within the last three years to reflect up to date clinical guidelines and should be referenced with care.
WCITD_2019_REVISE_Abstract_Submission_Confirmation
Evaluation of the efficacy and safety of endoscopically achieved proximal intestinal exclusion as an adjunct to glucagon-like peptide-1 therapy in Diabesity: REVISE-DIABESITY randomised clinical trial.
Authors:
P. Sen Gupta, B. McGowan, R. Drummond, S. Amiel, B. Ryder.
